Presentation is loading. Please wait.

Presentation is loading. Please wait.

Vivian A. Fonseca, MD, Lawrence A. Lavery, DPM, MPH, Tina K

Similar presentations


Presentation on theme: "Vivian A. Fonseca, MD, Lawrence A. Lavery, DPM, MPH, Tina K"— Presentation transcript:

1 Metanx in Type 2 Diabetes with Peripheral Neuropathy: A Randomized Trial 
Vivian A. Fonseca, MD, Lawrence A. Lavery, DPM, MPH, Tina K. Thethi, MD, Yahya Daoud, PhDC, Cyrus DeSouza, MD, Fernando Ovalle, MD, Douglas S. Denham, DO, Teodoro Bottiglieri, PhD, Peter Sheehan, MD, Julio Rosenstock, MD  The American Journal of Medicine  Volume 126, Issue 2, Pages (February 2013) DOI: /j.amjmed Copyright © 2013 Elsevier Inc. Terms and Conditions

2 Figure 1 Change in mean Neuropathy Total Symptom Score (NTSS-6) from baseline to 24 weeks. This questionnaire includes 6 yes-or-no questions about neuropathic symptoms including various types of pain, tingling, and loss of sensation. Each “yes” answer is scored as 1 point. Lower scores signify improvement. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2013 Elsevier Inc. Terms and Conditions


Download ppt "Vivian A. Fonseca, MD, Lawrence A. Lavery, DPM, MPH, Tina K"

Similar presentations


Ads by Google